268 related articles for article (PubMed ID: 20028780)
21. Characterization of extensively drug-resistant Mycobacterium tuberculosis in Nepal.
Poudel A; Maharjan B; Nakajima C; Fukushima Y; Pandey BD; Beneke A; Suzuki Y
Tuberculosis (Edinb); 2013 Jan; 93(1):84-8. PubMed ID: 23146281
[TBL] [Abstract][Full Text] [Related]
22. Genomic sequence based scanning for drug resistance-associated mutations and evolutionary analysis of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis.
Liu CH; Li HM; Lu N; Wang Q; Hu YL; Yang X; Hu YF; Woo PC; Gao GF; Zhu B
J Infect; 2012 Nov; 65(5):412-22. PubMed ID: 22728171
[TBL] [Abstract][Full Text] [Related]
23. Prediction of XDR/pre-XDR tuberculosis by genetic mutations among MDR cases from a hospital in Shandong, China.
Wang H; Zhang X; Luo T; Li X; Tian P; Xu Y; Gao Q
Tuberculosis (Edinb); 2014 May; 94(3):277-81. PubMed ID: 24751554
[TBL] [Abstract][Full Text] [Related]
24. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa.
Evans J; Stead MC; Nicol MP; Segal H
J Antimicrob Chemother; 2009 Jan; 63(1):11-6. PubMed ID: 18940875
[TBL] [Abstract][Full Text] [Related]
25. Quadruple-first line drug resistance in Mycobacterium tuberculosis in Vietnam: What can we learn from genes?
Nguyen HQ; Nguyen NV; Contamin L; Tran THT; Vu TT; Nguyen HV; Nguyen NLT; Nguyen ST; Dang AD; Bañuls AL; Nguyen VAT
Infect Genet Evol; 2017 Jun; 50():55-61. PubMed ID: 28214557
[TBL] [Abstract][Full Text] [Related]
26. GidB mutation as a phylogenetic marker for Q1 cluster Mycobacterium tuberculosis isolates and intermediate-level streptomycin resistance determinant in Lisbon, Portugal.
Perdigão J; Macedo R; Machado D; Silva C; Jordão L; Couto I; Viveiros M; Portugal I
Clin Microbiol Infect; 2014 May; 20(5):O278-84. PubMed ID: 24102832
[TBL] [Abstract][Full Text] [Related]
27. First Insight Into the Fluoroquinolone and Aminoglycoside Resistance of Multidrug-Resistant
Varghese B; Al-Hajoj S
Am J Trop Med Hyg; 2017 May; 96(5):1066-1070. PubMed ID: 28500800
[TBL] [Abstract][Full Text] [Related]
28. MIRU-VNTR typing of drug-resistant tuberculosis isolates in Greece.
Rovina N; Karabela S; Constantoulakis P; Michou V; Konstantinou K; Sgountzos V; Roussos C; Poulakis N
Ther Adv Respir Dis; 2011 Aug; 5(4):229-36. PubMed ID: 21474654
[TBL] [Abstract][Full Text] [Related]
29. [MDR, pre-XDR and XDR drug-resistant tuberculosis in Poland in 2000-2009].
Kozińska M; Brzostek A; Krawiecka D; Rybczyńska M; Zwolska Z; Augustynowicz-Kopeć E
Pneumonol Alergol Pol; 2011; 79(4):278-87. PubMed ID: 21678278
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of drug resistance in Mycobacterium tuberculosis.
Zhang Y; Yew WW
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1320-30. PubMed ID: 19861002
[TBL] [Abstract][Full Text] [Related]
31. The population structure of drug-resistant Mycobacterium tuberculosis clinical isolates from Sichuan in China.
Zhao Y; Feng Q; Tang K; Zhang C; Sun H; Luo T; Yang Z; Couvin D; Rastogi N; Sun Q
Infect Genet Evol; 2012 Jun; 12(4):718-24. PubMed ID: 21989209
[TBL] [Abstract][Full Text] [Related]
32. embCAB sequence variation among ethambutol-resistant Mycobacterium tuberculosis isolates without embB306 mutation.
Plinke C; Cox HS; Zarkua N; Karimovich HA; Braker K; Diel R; Rüsch-Gerdes S; Feuerriegel S; Niemann S
J Antimicrob Chemother; 2010 Jul; 65(7):1359-67. PubMed ID: 20427375
[TBL] [Abstract][Full Text] [Related]
33. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs.
Said HM; Kock MM; Ismail NA; Baba K; Omar SV; Osman AG; Hoosen AA; Ehlers MM
Int J Tuberc Lung Dis; 2012 Jan; 16(1):104-9. PubMed ID: 22236854
[TBL] [Abstract][Full Text] [Related]
35. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
[TBL] [Abstract][Full Text] [Related]
36. Genetic analysis of mycobacterium tuberculosis strains isolated in Ural region, Russian Federation, by MIRU-VNTR genotyping.
Kovalev SY; Kamaev EY; Kravchenko MA; Kurepina NE; Skorniakov SN
Int J Tuberc Lung Dis; 2005 Jul; 9(7):746-52. PubMed ID: 16013769
[TBL] [Abstract][Full Text] [Related]
37. Molecular characterization of amikacin, kanamycin and capreomycin resistance in M/XDR-TB strains isolated in Thailand.
Sowajassatakul A; Prammananan T; Chaiprasert A; Phunpruch S
BMC Microbiol; 2014 Jun; 14():165. PubMed ID: 24953243
[TBL] [Abstract][Full Text] [Related]
38. Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis.
Abbadi SH; Sameaa GA; Morlock G; Cooksey RC
Int J Infect Dis; 2009 Nov; 13(6):673-8. PubMed ID: 19138546
[TBL] [Abstract][Full Text] [Related]
39. Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by gyrA mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencing.
Shi R; Zhang J; Li C; Kazumi Y; Sugawara I
J Clin Microbiol; 2006 Dec; 44(12):4566-8. PubMed ID: 17035499
[TBL] [Abstract][Full Text] [Related]
40. Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016).
Kateete DP; Kamulegeya R; Kigozi E; Katabazi FA; Lukoye D; Sebit SI; Abdi H; Arube P; Kasule GW; Musisi K; Dlamini MG; Khumalo D; Joloba ML
BMC Pulm Med; 2019 Jul; 19(1):124. PubMed ID: 31291943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
